Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.34 | N/A |
| PEG Ratio (TTM) | -3.45 | N/A |
| P/S Ratio (TTM) | 1.35 | N/A |
| P/B Ratio (TTM) | 1.80 | N/A |
| P/FCF Ratio (TTM) | 12.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.76 | N/A |
| Price to 5YR AVG FCF Ratio | 18.43 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.77% | N/A |
| ROE (TTM) | 11.54% | N/A |
| Net Profit Margin (TTM) | 8.28% | N/A |
| ROIC 5YR AVG | 14.48% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.88% | 5.06% | 13.48% |
| Revenue | -0.97% | 10.94% | 7.14% |
| Net Income | 3.16% | 6.11% | 12.29% |
| Cash Flow | 77.16% | -24.11% | 77.11% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.09 | N/A |
| Quick Ratio (TTM) | 1.64 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.94 | N/A |
| LTL to 5YR AVG FCF | 0.37 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.84% | N/A |